Metagenomi, Inc. (MGX)
NASDAQ · Healthcare
Metagenomi, Inc. Operating Income 2023–2025
Metagenomi, Inc. annual/quarterly operating income history and growth rate from 2023 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Metagenomi, Inc. operating income for the quarter ending March 31, 2026 was -24.6 M, a 11.62% decrease year-over-year.
- Metagenomi, Inc. operating income for the twelve months ending March 31, 2026 was -96.2 M, a 6.13% increase year-over-year.
- Metagenomi, Inc. annual operating income for 2025 was -96.0 M, a 8.00% increase from 2024.
- Metagenomi, Inc. annual operating income for 2024 was -88.9 M, a 13.26% increase from 2023.
- Metagenomi, Inc. annual operating income for 2023 was -78.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Metagenomi, Inc. Operating Income — FAQ
Metagenomi, Inc. (MGX) operating income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Metagenomi, Inc.'s operating income?
Metagenomi, Inc. (MGX) reported operating income of -$96M for fiscal 2025.
Where can I see MGX's operating income history?
The chart and table above show Metagenomi, Inc.'s operating income by year and by quarter, including the growth rate.